BioLineRx (BLRX) Notes Payables (2012 - 2018)

BioLineRx (BLRX) recorded quarterly Notes Payables of $93000.0 in Q3 2018, little changed quarter-over-quarter from $93000.0 in Q2 2018, and little changed on a YoY basis from $93000.0 in Q3 2017.

BioLineRx (BLRX) Notes Payables (2012 - 2018) Analysis & Trends

BioLineRx's Notes Payables history runs 6 years deep, the most recent figure standing at $93000.0 for Q3 2018.

  • In Q3 2018, Notes Payables changed 0.0% year-over-year to $93000.0; the TTM figure through Sep 2018 stood at $93000.0 (changed 0.0% YoY), while the FY2017 annual figure was $93000.0, changed 0.0% from the prior year.
  • Notes Payables was $93000.0 for Q3 2018 at BioLineRx, roughly flat from $93000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $93000.0 in Q3 2015 to a low of $93000.0 in Q3 2015.
  • Historically, Notes Payables has averaged $93000.0 across 4 years, with a median of $93000.0 in 2015.
  • Biggest YoY gain for Notes Payables was 0.0% in 2016; the steepest drop was 0.0% in 2016.
  • A 4-year view of Notes Payables shows it stood at $93000.0 in 2015, then changed by 0.0% to $93000.0 in 2016, then changed by 0.0% to $93000.0 in 2017, then changed by 0.0% to $93000.0 in 2018.
  • The last three Notes Payables figures came in at $93000.0 (Q3 2018), $93000.0 (Q2 2018), and $93000.0 (Q1 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 BioLineRx 227.63 Mn 211.90 Mn 154,000.00

Historic Data

Download Data
DateValue
Sep 30, 2018 93,000.00
Jun 30, 2018 93,000.00
Mar 31, 2018 93,000.00
Dec 31, 2017 93,000.00
Sep 30, 2017 93,000.00
Jun 30, 2017 93,000.00
Mar 31, 2017 93,000.00
Dec 31, 2016 93,000.00
Sep 30, 2016 93,000.00
Jun 30, 2016 93,000.00
Mar 31, 2016 93,000.00
Dec 31, 2015 93,000.00
Sep 30, 2015 93,000.00
Mar 31, 2013 15,000.00
Dec 31, 2012 37,000.00